News & Events about Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the Company), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced the closing of its previously announced public offering of 1,265,000 common...
Establishment Labs Holdings Inc. (NASDAQ: ESTA) (the Company), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced the pricing of its public offering of 1,100,000 common shares at a price of...
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into agreements with four partners in Europe and a second partner chain in...
Establishment Labs Holdings Inc. (NASDAQ:ESTA Get Rating) Director Leslie Gillin sold 3,759 shares of the businesss stock in a transaction dated Wednesday, March 15th. The shares were sold at an average price of $67.62, for a total transaction of $254,183.58. Following the transaction...
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. (NASDAQ: ESTA) resulting from allegations that the Company may have issued materially misleading business information to the...